Arnold Library

An FCGR2C Polymorphism Associates with HIV-1 Vaccine Protection in RV144 Trial

Pattacini, Laura (2014) An FCGR2C Polymorphism Associates with HIV-1 Vaccine Protection in RV144 Trial. Science Spotlight, 4 (10).

[img]
Preview
Text
An FCGR2C Polymorphism Associates with HIV-1 Vaccine Protection in RV144 Trial.pdf - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (268Kb) | Preview
Article URL: http://www.jci.org/articles/view/75539
Item Type: Article
Additional Information: Li SS*, Gilbert P*, Tomaras GD, Kijak G, Ferrari G, Thomas R, Pyo CW, Zolla-Pazner S, Montefiori D, Liao HX, Nabel G, Pinter A, Evans DT, Gottardo R, Dai JY, Janes H, Morris D, Fong Y, Edlefsen PT, Li F, Frahm N, Alpert MD, Prentice H, Rerks-Ngarm S, Pitisuttithum P, Kaewkungwal J, Nitayaphan S, Robb ML, O'Connell RJ, Haynes BF, Michael NL, Kim JH, McElrath MJ, Geraghty DE. 2014 FCGR2C polymorphisms associate with HIV-1 vaccine protection in RV144 trial. J Clin Invest. 124(9):3879–3890. See also: JY Dai, SS Li, PB Gilbert. 2014. Case-only method for cause-specific hazards models with application to assessing differential vaccine efficacy by viral and host genetics. Biostatistics. 15(1): 196-203.
Collections: Science Spotlight
Depositing User: Ben Abraham
Date Deposited: 19 Mar 2015 21:17
Last Modified: 19 Mar 2015 21:17
URI: http://authors.fhcrc.org/id/eprint/801

Repository Administrators Only

View Item View Item
Fred Hutchinson Cancer Research Center
1100 Fairview Ave. N. PO Box 19024
Seattle, WA 98109

a 501(c)(3) nonprofit organization.

© Terms of Use & Privacy Policy